Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1.
de Sousa FTG, Warnes CM, Manuli ER, Tjang LV, Carneiro PH, Maria de Oliveira Pinto L, Ng A, Bhat S, Zambrana JV, D'Elia Zanella LGFAB, Ho YL, Romano CM, Beatty PR, Biering SB, Kallas EG, Sabino EC, Harris E. de Sousa FTG, et al. Among authors: harris e. EBioMedicine. 2024 Oct 24;109:105409. doi: 10.1016/j.ebiom.2024.105409. Online ahead of print. EBioMedicine. 2024. PMID: 39454515 Free article.
CAV Trajectories Among Patients With No or Mild CAV at 10 Years Posttransplant.
Harris E, Prasad N, Skoll D, Kumar SS, Fried J, Topkara V, Raikhelkar JK, DeFilippis EM, Latif F, Yuzefpolskaya M, Colombo PC, Uriel N, Takeda K, Sayer GT, Clerkin KJ. Harris E, et al. Clin Transplant. 2024 Oct;38(10):e70009. doi: 10.1111/ctr.70009. Clin Transplant. 2024. PMID: 39436145
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Elneima O, McAuley HJC, Leavy OC, Chalmers JD, Horsley A, Ho LP, Marks M, Poinasamy K, Raman B, Shikotra A, Singapuri A, Sereno M, Harris VC, Houchen-Wolloff L, Saunders RM, Greening NJ, Richardson M, Quint JK, Briggs A, Docherty AB, Kerr S, Harrison EM, Lone NI, Thorpe M, Heaney LG, Lewis KE, Aul R, Beirne P, Bolton CE, Brown JS, Choudhury G, Bakerly ND, Easom N, Echevarria C, Fuld J, Hart N, Hurst JR, Jones MG, Parekh D, Pfeffer P, Rahman NM, Rowland-Jones SL, Thompson AR, Jolley C, Shah AM, Wootton DG, Chalder T, Davies MJ, De Soyza A, Geddes JR, Greenhalf W, Heller S, Howard LS, Jacob J, Jenkins RG, Lord JM, Man WD, McCann GP, Neubauer S, Openshaw PJ, Porter JC, Rowland MJ, Scott JT, Semple MG, Singh SJ, Thomas DC, Toshner M, Smith N, Sheikh A, Brightling CE, Wain LV, Evans RA; PHOSP-COVID Collaborative Group. Elneima O, et al. Int J Epidemiol. 2024 Feb 1;53(1):dyad165. doi: 10.1093/ije/dyad165. Int J Epidemiol. 2024. PMID: 39429158 Free PMC article. No abstract available.
Time to rethink platinum choices in the era of immunotherapy in lung cancer.
Harris E, Taflin NF, Chitkara A, Tagliamento M, Bestvina CM, Vakkalagadda CV, Besse B, Thawani R. Harris E, et al. Ann Oncol. 2024 Oct 10:S0923-7534(24)04058-4. doi: 10.1016/j.annonc.2024.10.009. Online ahead of print. Ann Oncol. 2024. PMID: 39395538 No abstract available.
3,709 results